発疹の世界市場レポート 2025年

発疹の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.4％で27億1,000万米ドルに成長します。予測期間中の成長は、研究開発投資の増加、ウイルス・細菌感染症の流行増加、遠隔医療重視の高まり、政府イニシアチブの拡大、経口薬需要の高まりに起因すると考えられます。この期間の主な動向には、治療アプローチの進歩、診断技術の革新、技術の進歩、医学研究と技術の飛躍的進歩、支援技術の開発などがあります。

ウイルス感染症の有病率の増加が、今後数年間の発疹市場の成長を牽引すると予想されます。ウイルス感染症は、体内の細胞内に侵入して複製するウイルスによって引き起こされる病気で、さまざまな症状や病気を引き起こします。世界的な旅行の増加、都市化、気候変動、人口の免疫力低下などの要因が、ウイルス感染症の頻度上昇に寄与しています。皮疹を呈する症例が増えるにつれ、効果的な発疹治療の必要性が高まっています。発疹は、ウイルス感染に対する目に見える免疫反応として機能し、病原体の排出、免疫活性化のシグナル伝達、ウイルスに対する体の戦いを示すことによる診断補助などの役割を果たします。例えば、米国疾病予防管理センター（CDC）によると、2022年から2024年にかけて、最近のパルボウイルスB19感染を示すIgM抗体を持つ人の割合は3％未満で推移していましたが、2024年6月には10％に急増しました。最も顕著に上昇したのは5～9歳の小児で、この期間に有病率は15％から40％に上昇しました。その結果、ウイルス感染症の増加が発疹市場の成長を牽引しています。

発疹市場で事業を展開する企業は、ワクチンや抗ウイルス治療薬の筋肉内（IM）投与など、新たな治療法の開発に躍進しています。注射器と注射針を用いてワクチンや薬剤を筋肉組織に直接投与するこの方法は、血流への迅速な吸収を保証します。筋肉内の豊富な血液供給を利用することで、IM投与は治療や免疫反応を促し、治療効果を向上させます。例えば、2023年3月、Merck &Co.Inc.は、FDAがMMRVワクチン-M-R II、VARIVAX、ProQuadのIM投与経路を承認したと発表しました。この方法は、他の投与方法と比較して、これらの生ウイルスワクチンの安定性と有効性が高く、重篤なウイルス感染症を予防する公衆衛生の取り組みを強化する上で重要な一歩となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の発疹市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の発疹市場：成長率分析
• 世界の発疹市場の実績：規模と成長、2019～2024年
• 世界の発疹市場の予測：規模と成長、2024～2029年、2034年
• 世界の発疹総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の発疹市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細菌性
• ウイルス性
• その他
• 世界の発疹市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所治療
• 全身治療
• 支持療法
• 世界の発疹市場：診断方法別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床検査
• ラボ検査
• 画像技術
• 世界の発疹市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 麻疹
• 風疹
• 伝染性紅斑
• 小児突発性発疹
• 世界の発疹市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門センター
• その他
• 世界の発疹市場：細菌性のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 猩紅熱
• 髄膜炎菌血症
• ブドウ球菌性熱傷様皮膚症候群（SSSS）
• ライム病
• 結核関連発疹
• 世界の発疹市場：ウイルス性のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 麻疹
• 風疹
• 水痘（水ぼうそう）
• 突発性発疹
• 手足口病
• パルボウイルスB19（伝染性紅斑/五日熱）
• デング熱発疹
• ジカウイルス発疹
• 世界の発疹市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤誘発性発疹（過敏症反応）
• 自己免疫関連発疹（ループス、川崎病）
• アレルギー性皮膚炎関連発疹
• 真菌感染症による発疹
• 環境および毒素誘発性発疹

第7章 地域別・国別分析

• 世界の発疹市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の発疹市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 発疹市場：競合情勢
• 発疹市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Company Limited
• Amgen Inc.
• Daiichi Sankyo Company Limited
• Biological E. Limited
• Zydus Lifesciences Limited
• Bio Farma
• Meridian Bioscience Inc.
• West-Ward Pharmaceutical Corp.
• Trinity Biotech plc
• Biosynth Srl
• Creative Diagnostics
• Taj Pharmaceuticals Limited
• TestLine Clinical Diagnostics s.r.o.
• The Native Antigen Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 発疹市場2029：新たな機会を提供する国
• 発疹市場2029：新たな機会を提供するセグメント
• 発疹市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Exanthema is a term used to describe a widespread skin rash or eruption, often resulting from a viral infection such as measles, rubella, or chickenpox (varicella). It plays a crucial role in diagnosing and identifying viral illnesses, as the rash's specific characteristics can help healthcare professionals determine the cause of the infection and decide on the most suitable treatment and management approaches.

The primary types of exanthema include bacterial, viral, and other forms. Bacterial exanthema is caused by infections from bacteria such as Streptococcus or Staphylococcus, leading to skin rashes. Treatment options involve topical medications, systemic therapies, and supportive care, with diagnostic methods including clinical examination, laboratory tests, and imaging techniques. Common conditions associated with exanthema include rubeola, rubella, erythema infectiosum, and roseola infantum. These diagnostic and treatment approaches are used by various healthcare providers, including hospitals, homecare services, and specialty centers.

The exanthema market research report is one of a series of new reports from The Business Research Company that provides exanthema market statistics, including the exanthema industry global market size, regional shares, competitors with the exanthema market share, detailed exanthema market segments, market trends, and opportunities, and any further data you may need to thrive in the exanthema industry. This exanthema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exanthema market size has grown steadily in recent years. It will grow from $2.18 billion in 2024 to $2.28 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be attributed to factors such as higher healthcare spending, increased awareness about vaccination, rising disposable incomes, greater understanding of skin disorders, and a stronger focus on early detection.

The exanthema market size is expected to see steady growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth during the forecast period can be attributed to increased investments in research and development, a higher prevalence of viral and bacterial infections, a growing emphasis on telemedicine, expanding government initiatives, and a rising demand for oral medications. Key trends during this period include advancements in treatment approaches, innovations in diagnostic techniques, technological progress, breakthroughs in medical research and technology, and the development of assistive technologies.

The increasing prevalence of viral infections is expected to drive the growth of the exanthema market in the coming years. Viral infections are illnesses caused by viruses that invade and replicate within the body's cells, resulting in various symptoms and diseases. Factors such as global travel, urbanization, climate change, and weakened immunity in populations are contributing to the rising frequency of viral infections. As more cases present with skin rashes, there is a growing need for effective exanthema treatments. Exanthema, which serves as a visible immune response to viral infections, plays a role in expelling pathogens, signaling immune activation, and assisting in diagnosis by showing the body's fight against the virus. For example, according to the Centers for Disease Control and Prevention (CDC), between 2022 and 2024, the percentage of individuals with IgM antibodies, which indicate a recent Parvovirus B19 infection, remained below 3%, but surged to 10% by June 2024. The most significant rise occurred among children aged 5-9, where the prevalence increased from 15% to 40% during this period. As a result, the increasing prevalence of viral infections is driving the growth of the exanthema market.

Companies operating in the exanthema market are making strides in developing new therapeutics, including intramuscular (IM) administration of vaccines and antiviral treatments. This method, which involves delivering vaccines or medications directly into the muscle tissue via a syringe and needle, ensures quick absorption into the bloodstream. By leveraging the rich blood supply in the muscles, the IM administration prompts a therapeutic or immune response, improving the efficacy of the treatment. For example, in March 2023, Merck & Co. Inc. announced that the FDA had approved the IM administration route for its MMRV vaccines-M-M-R II, VARIVAX, and ProQuad. This method offers greater stability and efficacy for these live-virus vaccines compared to other administration methods, making it a key step in enhancing public health efforts to prevent severe viral infections.

In September 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for $1.2 billion. Dermavant Sciences is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics in immunodermatology. This acquisition strengthens Organon's position in the dermatology field and aligns with its objectives to expand its portfolio with cutting-edge therapies.

Major players in the exanthema market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi SA, Abbott Laboratories, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Amgen Inc., Daiichi Sankyo Company Limited, Biological E. Limited, Zydus Lifesciences Limited, Bio Farma, Meridian Bioscience Inc., West-Ward Pharmaceutical Corp., Trinity Biotech plc, Biosynth Srl, Creative Diagnostics, Taj Pharmaceuticals Limited, TestLine Clinical Diagnostics s.r.o., The Native Antigen Co. Ltd., and QED Bioscience Inc.

North America was the largest region in the exanthema market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in exanthema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the exanthema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The exanthema market consists of revenues earned by entities by providing services such as antiviral treatment services, vaccination services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The exanthema market also includes sales of topical corticosteroids, antihistamines, immunosuppressants, antiviral medications, and moisturizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exanthema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exanthema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exanthema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exanthema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Bacterial; Viral; Other Types
• 2) By Treatment: Topical Treatments; Systemic Treatments; Supportive Care
• 3) By Diagnosis Method: Clinical Examination; Laboratory Tests; Imaging Techniques
• 4) By Application: Rubeola; Rubella; Erythema Infectiosum; Roseola Infantum
• 5) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
• Subsegments:
• 1) By Bacterial Exanthema: Scarlet Fever; Meningococcemia; Staphylococcal Scalded Skin Syndrome (SSSS); Lyme Disease; Tuberculosis-Associated Exanthema
• 2) By Viral Exanthema: Measles (Rubeola); Rubella (German Measles); Varicella (Chickenpox); Roseola (Exanthem Subitum); Hand, Foot, and Mouth Disease; Parvovirus B19 (Erythema Infectiosum / Fifth Disease); Dengue Fever Rash; Zika Virus Rash
• 3) By Other Types of Exanthema: Drug-Induced Exanthema (Hypersensitivity Reactions); Autoimmune-Related Exanthema (Lupus, Kawasaki Disease); Allergic Dermatitis-Related Exanthema; Fungal Infections Leading to Exanthema; Environmental and Toxin-Induced Exanthema
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi SA; Abbott Laboratories; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exanthema Market Characteristics

3. Exanthema Market Trends And Strategies

4. Exanthema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Exanthema Growth Analysis And Strategic Analysis Framework

• 5.1. Global Exanthema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Exanthema Market Growth Rate Analysis
• 5.4. Global Exanthema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Exanthema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Exanthema Total Addressable Market (TAM)

6. Exanthema Market Segmentation

• 6.1. Global Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial
• Viral
• Other Types
• 6.2. Global Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments
• Systemic Treatments
• Supportive Care
• 6.3. Global Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Examination
• Laboratory Tests
• Imaging Techniques
• 6.4. Global Exanthema Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rubeola
• Rubella
• Erythema Infectiosum
• Roseola Infantum
• 6.5. Global Exanthema Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End-Users
• 6.6. Global Exanthema Market, Sub-Segmentation Of Bacterial Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Scarlet Fever
• Meningococcemia
• Staphylococcal Scalded Skin Syndrome (SSSS)
• Lyme Disease
• Tuberculosis-Associated Exanthema
• 6.7. Global Exanthema Market, Sub-Segmentation Of Viral Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Measles (Rubeola)
• Rubella (German Measles)
• Varicella (Chickenpox)
• Roseola (Exanthem Subitum)
• Hand, Foot, and Mouth Disease
• Parvovirus B19 (Erythema Infectiosum / Fifth Disease)
• Dengue Fever Rash
• Zika Virus Rash
• 6.8. Global Exanthema Market, Sub-Segmentation Of Other Types of Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Induced Exanthema (Hypersensitivity Reactions)
• Autoimmune-Related Exanthema (Lupus, Kawasaki Disease)
• Allergic Dermatitis-Related Exanthema
• Fungal Infections Leading to Exanthema
• Environmental and Toxin-Induced Exanthema

7. Exanthema Market Regional And Country Analysis

• 7.1. Global Exanthema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Exanthema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exanthema Market

• 8.1. Asia-Pacific Exanthema Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exanthema Market

• 9.1. China Exanthema Market Overview
• 9.2. China Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exanthema Market

• 10.1. India Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exanthema Market

• 11.1. Japan Exanthema Market Overview
• 11.2. Japan Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exanthema Market

• 12.1. Australia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exanthema Market

• 13.1. Indonesia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exanthema Market

• 14.1. South Korea Exanthema Market Overview
• 14.2. South Korea Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exanthema Market

• 15.1. Western Europe Exanthema Market Overview
• 15.2. Western Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exanthema Market

• 16.1. UK Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exanthema Market

• 17.1. Germany Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exanthema Market

• 18.1. France Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exanthema Market

• 19.1. Italy Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exanthema Market

• 20.1. Spain Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exanthema Market

• 21.1. Eastern Europe Exanthema Market Overview
• 21.2. Eastern Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exanthema Market

• 22.1. Russia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exanthema Market

• 23.1. North America Exanthema Market Overview
• 23.2. North America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exanthema Market

• 24.1. USA Exanthema Market Overview
• 24.2. USA Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exanthema Market

• 25.1. Canada Exanthema Market Overview
• 25.2. Canada Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exanthema Market

• 26.1. South America Exanthema Market Overview
• 26.2. South America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exanthema Market

• 27.1. Brazil Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exanthema Market

• 28.1. Middle East Exanthema Market Overview
• 28.2. Middle East Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exanthema Market

• 29.1. Africa Exanthema Market Overview
• 29.2. Africa Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exanthema Market Competitive Landscape And Company Profiles

• 30.1. Exanthema Market Competitive Landscape
• 30.2. Exanthema Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Exanthema Market Other Major And Innovative Companies

• 31.1. Serum Institute of India Pvt. Ltd.
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Amgen Inc.
• 31.4. Daiichi Sankyo Company Limited
• 31.5. Biological E. Limited
• 31.6. Zydus Lifesciences Limited
• 31.7. Bio Farma
• 31.8. Meridian Bioscience Inc.
• 31.9. West-Ward Pharmaceutical Corp.
• 31.10. Trinity Biotech plc
• 31.11. Biosynth Srl
• 31.12. Creative Diagnostics
• 31.13. Taj Pharmaceuticals Limited
• 31.14. TestLine Clinical Diagnostics s.r.o.
• 31.15. The Native Antigen Co. Ltd.

32. Global Exanthema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exanthema Market

34. Recent Developments In The Exanthema Market

35. Exanthema Market High Potential Countries, Segments and Strategies

• 35.1 Exanthema Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Exanthema Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Exanthema Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer